Owen Jones received his PhD from the University of Manchester (2002), UK, developing a PBPK model for a series of methacrylate monomers looking at target tissue exposures via inhalation. He then joined AstraZeneca as a pharmacokinetic modeler within the Oncology research area. Over the last 15 years he has held several roles within the DMPK organization supporting Oncology projects. Over the last 10 years he has increasingly focused his attention to PKPD modelling, and has driven the implementation of pre-clinical PKPD modelling within the research organisation, and currently leads a team of mathematical modelers that support the Oncology small molecule portfolio.
Current Role: Associate Director, Oncology DMPK